Medgenics Inc (NYSE MKT LLC:MDGN)

8.20
Delayed Data
As of 12:44pm ET
 -0.02 / -0.24%
Today’s Change
3.68
Today|||52-Week Range
8.50
+62.06%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 11.50, with a high estimate of 11.50 and a low estimate of 11.50. The median estimate represents a +40.24% increase from the last price of 8.20.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$0.00
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.33%
 
 
 
 
 
 
Growthannually -13.00%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually 0.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account